ClinicalTrials.gov
ClinicalTrials.gov Menu

Randomized Trial of Pegylated Interferon Alfa-2a Versus Hydroxyurea in Polycythemia Vera (PV) and Essential Thrombocythemia (ET)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01259856
Recruitment Status : Completed
First Posted : December 14, 2010
Last Update Posted : January 24, 2018
Sponsor:
Collaborators:
Myeloproliferative Disorders-Research Consortium
National Cancer Institute (NCI)
Roche Pharma AG
Information provided by (Responsible Party):
Ronald Hoffman, Icahn School of Medicine at Mount Sinai

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : June 30, 2017
  Actual Study Completion Date : June 30, 2017